AbstractThe report is based on the study of annual reports of Cipla bear and Sun Pharmaceutical Industries Limited for the five years from 2003-2004 to 2007-2008. The main(prenominal) objective of this study was to apply the concepts learned as a part of this course and understand the business, monetary health and the fib practices followed by these companies. As a part of this report we require tried to analyze the current and past performance trends for the company and predict the future performance and stock prices of the company. To achieve this we desexualize analyzed Revenue Trends, Profitability, Liquidity, Debts, Stocks, Cash Flows and provided a summary at the end of the report. The scope of the report is limited to our understanding of the pecuniary Statements based on the current course. The report has to be seen in its completeness along with the excel worksheet containing the past five years financial data of the two firms and various ratios. IntroductionC ipla is a leading pharmaceutic company in India and it is one of the largest exporters of drugs from India with exports contributing around 50% of its annual revenues. It offers a comprehensive range of products ranging from anti-asthma, cardiac to critical care drugs. Over the past 3 years the internal revenue has grown at a rate of 12% and the export revenue at 27% .
Sun Pharmaceuticals is a Mumbai based multinational company employing over 8,000 people and manufacturing facilities in 19 countries. It specializes in chronic ailment drugs and has been consistently spike out market share in India. The recent ac quisitions of Caraco Pharm has helped Sun to! determine up its global presence. Cipla and Sun Pharmaceuticals are comparable companies in harm of revenues and profits which makes it easier to compare the two companies and understand the concepts of... If you essential to tolerate a full essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page:
write my paper
No comments:
Post a Comment